Crossmark

Clinical impact of bronchoalveolar lavage fluid metagenomic next-generation sequencing in immunocompromised patients with severe community-acquired pneumonia in ICU: a multicenter retrospective study

Crossref DOI link: https://doi.org/10.1007/s15010-025-02520-0

Published Online: 2025-04-23

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Junjie

Zhuge, Runxi

Hu, Bangchuan

Wang, Yesong

Wang, Xingxing

Zhang, Yi

Yuan, Lingmin

Qiu, Canhu

Yan, Youqin

Zhang, Xiaojing

Hua, Zhidan

Tang, Jing

Guo, Kai

Sun, Yong

Wang, Kaiyu

Qiu, Liyan

Luo, Jian

Zhang, Weiwen

Zhuge, Jiancheng

Fang, Honglong
Funding

Funding for this research was provided by:

The Project of Zhejiang Provincial Department of Health (2023KY1296)

Quzhou Bureau of Science and Technology (2022K71)
License Information

Text and Data Mining valid from 2025-04-23

Version of Record valid from 2025-04-23
More Information

Article History

Received: 27 November 2024

Accepted: 20 March 2025

First Online: 23 April 2025

Declarations

:

: The authors declare no competing interests.

: The retrospective studies involving humans were approved by the ethics committee of Quzhou People’s Hospital (Quzhou People’s Hospital, Quzhou, China: Number B 2024–150). The studies were conducted in accordance with local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements.

: Not applicable.

Document is current

Any future updates will be listed below